Stockreport

Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker [Seeking Alpha]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF These two drugs alone support a "buy" thesis for Acadia. Learning from previously rejected drugs adds to the value of its strong late-stage pipeline. Solid liquidit [Read more]